Syndicated Loan Financing

BGPartner advises Swixx Biopharma Ltd. on a EUR 52 mio loan facility agreement with a syndicat of three major banks.

read more
Mastering Law and Negotiation

We create solution spaces that inspire.

read more
Successful negotiation

In our videos we take a closer look on what negotiating actually is and how you can lay a solid foundation for making it successful.

watch the video
Successful financing round

BGPartner advised Araris Biotech in a $24 million financing round. 

read more
Vis Moot Court Trial Round 2023

This year we had the privilege of hosting the teams of Universität Bern, Université de Genève and Universität Zürich


watch the video
M&A transaction

Successful closing. BGPartner advises on international M&A transaction.

read more

Swedish SynAct Pharma acquires Swiss biotech company TXP Pharm

read more

BGPartner – Mastering Law and Negotiation

We are a leading, nationally and internationally oriented law firm specialized in business law and negotiation. We create solution spaces that inspire.

It is our goal to be your partner of choice for intelligent solutions by mastering law and negotiation. We stand for comprehensive advice, availability, flexibility and efficiency. Our dedicated and experienced team of lawyers is active in an advisory and litigation capacity for both enterprises and individuals.

BGPartner was founded in 1988, has offices in Berne and Zurich and is strongly affiliated with the Swiss legal network and the international legal network LAWorld. We can draw on the expertise of specialists in all language regions in Switzerland and from all over the world in no time. 

BGPartner – Mastering Law and Negotiation


13. March 2023

Vis Moot Court Trial Round 2023

This year we had the privilege of hosting the teams of Universität Bern, Université de Genève and University Zürich who did an outstanding job with their pleadings. Find out in the After Movies what the students benefited most from, how realistic a trial round is, what the preparation…

07. March 2023

BGPartner advises co-lead investors Forbion and Jeito Capital in USD 112 mio Ser…

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused investment firms Forbion and JEITO Capital. UPMC Enterpr…


  • Banking and Financial Market Law

  • Civil right

  • Company Law

  • Construction and Planning Law

  • Contract Law

  • Litigation and Arbitration

  • M&A / Private Equity and Venture Capital

  • Trade & Export Finance